Advent Proposed $1.02 Cash Take-Private of Definitive Healthcare:
Definitive Healthcare Corp. (DH) received a non-binding take-private proposal from Advent International for $1.02 per share. The offer is subject to review by a special committee and requires founder Jason Krantz's equity rollover. No binding agreement exists yet, and Advent may withdraw or modify the proposal.
How this was made
The 30-second read
Why it matters
The proposal signals possible consolidation in the healthcare data space and may trigger valuation reassessment.
Market read
First‑report M&A indication could move DH stock and influence sector sentiment.
What to watch
Potential regulatory review and founder roll‑over terms could affect deal completion.
Background
Definitive Healthcare Corp. (DH) disclosed receipt of Advent International's non‑binding indication of interest for a cash take‑private at $1.02 per share.
Ticker impact
Advent International submitted a non-binding $1.02 per share cash take‑private indication for Definitive Healthcare (DH).
Short‑term downside risk of 5‑10% if market perceives valuation pressure.
Take‑private offers often trigger sell‑offs until a definitive agreement is signed.
Market effects
Healthcare data and analytics sector may see increased M&A interest.
U.S. market may see modest pressure on similar mid‑cap healthcare stocks.
Limited to U.S. investors; no immediate global ripple.
Counterpoint
If Advent withdraws, DH could rebound on speculation of alternative suitors.
Key entities
- companyDefinitive Healthcare Corp.
Target of the take‑private proposal.
- investment_firmAdvent International L.P.
Potential acquirer submitting the indication of interest.
